Edition:
India

Advanced Enzyme Technologies Ltd (ADEN.NS)

ADEN.NS on National Stock Exchange of India

168.15INR
10:31am IST
Change (% chg)

Rs1.20 (+0.72%)
Prev Close
Rs166.95
Open
Rs166.00
Day's High
Rs169.00
Day's Low
Rs165.00
Volume
10,687
Avg. Vol
404,639
52-wk High
Rs232.90
52-wk Low
Rs146.80

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy 2.40 March 26 Jun 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 0 0 0 0
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.00 1.00 1.00 1.00

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 1 1,065.00 1,065.00 1,065.00 --
Year Ending Mar-20 1 4,699.00 4,699.00 4,699.00 5,396.00
Year Ending Mar-21 1 5,404.00 5,404.00 5,404.00 --
Earnings (per share)
Quarter Ending Mar-19 1 2.40 2.40 2.40 --
Year Ending Mar-20 1 12.10 12.10 12.10 14.50
Year Ending Mar-21 1 14.50 14.50 14.50 --

Historical Surprises

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-19 1,065.00 1,104.16 39.16 3.68
Quarter Ending Dec-18 1,153.00 1,017.41 135.59 11.76
Quarter Ending Sep-18 1,086.00 1,031.51 54.49 5.02
Quarter Ending Jun-18 1,081.00 1,042.83 38.17 3.53
Quarter Ending Mar-18 1,149.81 1,086.28 63.53 5.53

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 1,065.00 -- -- -- --
Year Ending Mar-20 4,699.00 4,699.00 -- -- 5,396.00
Year Ending Mar-21 5,404.00 5,404.00 -- -- --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 -- -- -- --
Year Ending Mar-20 0 0 -- --
Year Ending Mar-21 0 0 -- --
Earnings